LRP6 and plasma cell myeloma: Despite the fact that changes in bone formation in response to anti‐LRP6/DKK1 combination were not observed within the context of myeloma in 5TGM1‐bearing mice, the anti‐resorptive ability with this combination strategy was far superior when compared to anti‐LRP6 alone.